Cambridge Healthtech Institute’s 10th Annual

Enrollment Planning and Patient Recruitment:  

Successful Recruitment Planning, Forecasting, and Central Campaign Management
January 24-25, 2017 | Hyatt Regency Miami | Miami, FL


Patient recruitment and up-front enrollment planning are critical to drug development programs. Patient recruitment, if not adequately planned for, can extend your development timeline by a number of years. Retention of patients throughout the life of a clinical trial is essential in order to have complete data sets for your analysis and subsequent filings. In order to optimize both, you have to have a plan and it should take into account all stakeholders from senior management at the sponsor company and the CRO partners, to the sites and investigators and study volunteers. Cambridge Healthtech Institute’s 10th Annual “Enrollment Planning and Patient Recruitment” conference will cover the topics one should consider when drafting and strategically implementing a patient recruitment plan for a clinical development program.

Preliminary Agenda

Stay on and attend Part 2: Engagement and Retention
Keynotes | Monday Short Courses | Speaker Biographies

Monday, January 23

Recommended Pre-Conference Short Course
2:00 pm - 6:00 pm
SC1: Social Media, Digital Marketing and Technology Growth Hacks to Enroll Patients Faster *
*Separate registration required

Welcome and Networking Happy Hour on the Patio hosted by CHI, DrugDev and Praxis
6:30 pm - 8:30 pm

Tuesday, January 24 – Wednesday, January 25


OPENING PLENARY KEYNOTES
RE-THINKING THE DESIGN AND PLANNING OF OUR STUDIES


Two Keynote Sessions – Tuesday Morning and Wednesday Afternoon

  • Tuesday Morning: RE-THINKING THE DESIGN AND PLANNING OF OUR STUDIES
  • Wednesday Afternoon: MOVING TOWARD TRIALS OF THE FUTURE

Featuring:
Murray Abramson, M.D., Vice President, Global Clinical Operations, Biogen
Bardia Akbari, Pharm.D., Vice President, Product Global Development, Oncology, Genentech, Inc.
Robert DiCicco, Pharm.D., Vice President, Clinical Innovation and Digital Platforms, GlaxoSmithKline
Craig Lipset, MBA, Head of Clinical Innovation, R&D, Pfizer, Inc.
Paulo Moreira, Vice President, Global Clinical Operations - External Innovation, EMD Serono, Inc.
Christine Pierre, President, Society for Clinical Research Sites (SCRS)
John Reites, Head, Digital Health Acceleration, Quintiles
Jeremy Sohn, Vice President, Head of Digital Business Development & Licensing, Novartis
Katherine Vandebelt, Senior Director, Clinical Innovation, Eli Lilly and Company

For more details on the Tuesday Opening Plenary Keynote and Wednesday Afternoon Plenary Keynote click here.


Grand Opening Coffee Break in the Exhibit Hall


MOVING RECRUITMENT PLANNING UPSTREAM, DATA-DRIVEN RECRUITMENT & NEW PARADIGM OF PATIENT-CENTERED TRIALS

Chairperson’s Remarks

Pfizer’s Approach to Improving Operational Predictability
Mohanish Anand, Ph.D., Senior Director and Head, Feasibility Center of Excellence, Development Operations, Pfizer

Moving Recruitment Planning Upstream to Reduce Barriers to Participation: Recommendations from the CTTI Recruitment Planning Project
Beth Mahon, Associate Director, Global Clinical Operations - US, Janssen Research and Development

Recruiting & Consenting Patients Digitally: Facilitating the New Paradigm of Patient-Centered Trials
Nariman Nasser, Digital Strategist, Genentech

Sponsored Presentation by DAC

Luncheon Presentation by Praxis

INTEGRATING PATIENT INSIGHTS AND DIVERSITY INTO CLINICAL TRIAL PLANNING

Chairperson’s Remarks

Understanding and Implementing the New Reality of Diversity in Clinical Trials
Karen Brooks, Ph.D., Senior Director, Clinical Operations, Adare Pharmaceuticals

Case Study: Operationalizing Diversity Initiatives in Clinical Research, a Hep-C Story
Marisa Rackley, Director, Clinical Research, Global Trial Optimization, Merck

INTERACTIVE PANEL: Improving Patient Diversity in Clinical Trials with Real-Time Enrollment Monitoring
Moderator: Robert Loll, Vice President, Business Development & Strategic Planning, Praxis
Fabian Sandoval, M.D., CEO & Medical Director, Emerson Clinical Research Institute
Marisa Rackley, Director, Clinical Research, Global Trial Optimization, Merck
Lori Abrams, Director, Diversity & Patient Engagement, Global Clinical Operations, Bristol-Myers Squibb

This panel will discuss the lack of diversity in our enrollment demographics and address these key points in an interactive format:

  • Understand the current state of diversity and why it’s important to the FDA
  • Review Merck’s successful Hep-C program and how it worked to achieve these goals
  • Learn how to operationalize the activities to support diversity in clinical trials
  • Learn from sponsor, site and vendor perspectives how new techniques can make a big difference – through site selection, patient recruitment, site management and technology tools

Sponsored Presentation by Quintiles
Accelerate Clinical Trial Recruitment and Engage Healthcare Providers as Referral Sources with Specialized Clinical Field Resources
Stewart Rosen, M.D., Vice President of Medical Affairs, Quintiles Health Management Solutions, Quintiles


INTERACTIVE BREAKOUT DISCUSSION GROUPS

Concurrent breakout discussion groups are interactive, guided discussions hosted by a facilitator or set of co-facilitators to discuss some of the more poignant questions facing the industry. Delegates will join a table of interest to them and become an active part of the discussion at hand. It is an informal, yet informative, format that allows attendees to learn from each other and make some new contacts. To get the most out of this interactive format, please come prepared to: share examples from your work, vet some ideas with your peers, be a part of group interrogation and problem solving, and, most importantly, participate in active idea sharing.

View Detailed Interactive Breakout Discussion Groups

Welcome Reception in the Exhibit Hall


Breakfast Presentation sponsored by DrugDev


EFFECTIVELY ENGAGING WITH TRIAL PARTICIPANTS AND PATIENT ADVISORY BOARDS (PABs) TO OVERCOME RECRUITMENT CHALLENGES

Chairperson’s Remarks
Mark Summers, CEO & President, ThreeWire, Inc.

Overcoming Recruitment Challenges in Rare Disease
Elizabeth Carfioli, Associate Director, Patient Recruitment, Clinical Operations, Alnylam Pharmaceuticals

Increasing Recruitment and Retention through Comprehensive Patient Engagement Platform & Patient Advisory Boards (PABs)
Paulo Moreira, Vice President, Global Clinical Operations - External Innovation, EMD Serono, Inc.

Sponsored Presentation by Bioclinica


CHANGING HOW WE COMMUNICATE TO PARTICIPANTS

PatientEngagementAward  

NEW this year… SCOPE’s 2017 Participant Engagement Award
brought to you by CHI’s SCOPE and Patient Enrollment Advisors
The 2017 Participant Engagement Award is designed to inspire innovation and change in how we communicate to participants in the fields of Recruitment and Retention for clinical trials. Cambridge Healthtech Institute (CHI)’s SCOPE and Patient Enrollment Advisors welcome submissions from every aspect of the industry including Sites, CROs, Agencies and Sponsors alike to submit their best work in the Patient Recruitment and Retention communications field.
Panel of Judges:
David Sall, President & CEO, Patient Enrollment Advisors
Kelly McKee, Advisor, Clinical Innovation, Eli Lilly and Co.
Jean-Christian Philippi, Founder and Chief Strategy Officer, One Creative
Mark Sloan, M.D., Hematology & Medical Oncology, Boston Medical Center

        Submit your entry for SCOPE’s 2017 Participant Engagement Award
 
CLICK HERE for details
CLICK HERE for the Entry Form
Deadline for submission is November 18, 2016


RECRUITMENT IN A RESOURCE CONSTRAINED ENVIRONMENT: TRADITIONAL TACTICS, NEW TECH-ANALYTICS, ENGAGEMENT

Chairperson’s Remarks

INTERACTIVE PANEL: Recruitment in a Resource Constrained Environment: Do Past Tactics Still Give the Same Outcome in Present Day Scenarios?
Moderator: Richard Mayewski, Associate Director, Clinical Trial Intelligence, Global Clinical Trial Leadership, Novartis
Nariman Nasser, Digital Strategist, Genentech
Madeline Geday, Associate Director, Clinical Research, Global Trial Optimization, Merck & Co
Mohanish Anand, Ph.D., Senior Director and Head, Feasibility Center of Excellence, Development Operations, Pfizer

An introspective panel looking at the current landscape we face when trying to enroll patients in a study. Panelists will provide 2 scenarios outlining the tactics used to support the trial, while involving the audience to further the discussion. Topics such as Patient Engagement, increased need for justification in site selections by regulatory authorities, as well as decreased recruitment dollars will be discussed.

  • Reinforcement of tactics potentially already known, but potentially not selected due to potential archaic nature
  • Introduction to tactics not known or considered
  • Industry perspective into how similar all of our trial concerns are
  • Help vendors also understand that more must be done with less and bidding may be significantly lower than typical

Bridging Luncheon Presentation Sponsored by Clinithink
A Breakthrough in Technology Enabled Clinical Trials Recruitment
Steven Coca, M.D., Associate Professor of Medicine, Internal Medicine, Icahn School of Medicine, Mount Sinai

Stay on and attend Part 2: Engagement and Retention
Keynotes | Monday Short Courses | Speaker Biographies

2017 SCOPE Conference at a Glance

SCOPE 2016 Wrap-Up

The 7th Annual SCOPE Summit, held February 23-25, 2016 in Miami, Florida, had record attendance with more than 1,150 industry leaders joining 3 days of in-depth discussions covering important issues in clinical trial planning and management. As SCOPE grew in attendance by 30% over last year, the 2016 program offered 12 distinct conference tracks, 2 symposia, 3 short courses, and 4 plenary keynote sessions, focused on advances and innovative solutions in all aspects of clinical trial management and operations, including Data Integration, Feasibility, Site Selection and Management, Patient Engagement, Recruitment and Retention, Mobile Tech, Project Management, Outsourcing, Forecasting, Budgeting and Contracting, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Post-Marketing Studies, Observational Research, Statistics and Biomarker-Driven Trials.

For Further Information

For questions or suggestions about the meeting, please contact:

Micah Lieberman
Executive Director, Conferences
Cambridge Healthtech Institute (CHI)
T: (+1) 541.482.4709
E: mlieberman@healthtech.com

For partnering and sponsorship information, please contact:

Ilana Quigley
Senior Manager, Business Development
Cambridge Healthtech Institute (CHI)
T: (+1) 781.972.5457
E: iquigley@healthtech.com

For media and association partnerships, please contact:

Rich Handy
Senior Director, Marketing
Cambridge Healthtech Institute (CHI)
T: (+1) 781.972.5456
E: rhandy@healthtech.com



2017 SCOPE Conference at a Glance

Scope Final Agenda 2016  

Signature Sponsor

Bio Clinica Logo

Premier Sponsors

BBK  

ClinicalInk

Comprehend

Drug Dev

inVentivHealth

OmniComm

Parexel NEW

PRA Health Sciences

QUINTILES

> All Sponsors

> Media Partners

> 2016 Attendee List

> 2016 Attendee Profile